Serum Institute rejects charges levelled by vaccine trial participant, seeks ₹100 crore damages from volunteer

Vaccine major Serum Institute of India on Sunday rejected charges that a COVID-19 vaccine candidate has serious side effects, and threatened to seek heavy damages for “malicious” allegations.